Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study

被引:1
|
作者
Li, Longhao [1 ]
Yi, Xin [1 ]
Cui, Haixia [1 ]
Zhao, Xuemei [2 ]
Dang, Jun [1 ]
Jiang, Qingfeng [1 ]
Li, Ying [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China
[2] Dazu Dist Peoples Hosp, Dept Oncol, Chongqing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
gastrointestinal stromal tumors; locally advanced; drug-resistant; simultaneous integrated boost; intensity-modulated radiation therapy; RADIATION-THERAPY; GIST; MANAGEMENT; IMATINIB;
D O I
10.3389/fonc.2020.545892
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background As an emerging clinical problem, locally advanced drug-resistant gastrointestinal stromal tumors (LADRGISTs) has relatively few therapeutic schemes. Although radiotherapy is not often considered for GISTs, it could be a valuable contributing modality. The aim of our study is to explore a safe and effective radiation regimen for LADR-GISTs. Methods Three patients with LADR-GISTs were treated with simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) plans. In the SIB-IMRT plans, gross target volume (GTV) was divided into GTV-outer, GTV-mid, and GTV-center. And the prescribed dose of planning gross target volume (PGTV) and GTV-outer were both set to 50.4 Gy in 28 fractions. GTV-mid and GTV-center were simultaneously boosted to 60-62 Gy and 62-64 Gy respectively. For comparison purposes, conventional IMRT (Con-IMRT) plans with uniform dose distribution were generated for same optimization objectives without a dose boost to GTV-mid and GTV-center. All plans were optimized to make sure that deliver at least 95% of the prescription dose was delivered to PGTV. Isodose distribution, dose profiles, conformity indexes (CIs), monitor units (MUs), and dose volume histogram (DVH) was evaluated for each individual patient. After the three patients were treated with SIB-IMRT plans, the relative changes in the tumor size and CT values by CT scanning were also tracked. Results Compared with Con-IMRT plans, SIB-IMRT plans saw a significant increase from D-95 to D-2 of the GTV. With steeper dose gradients in the dose profiles, SIB-IMRT plans had GTV-mid and GTV-center accumulated with higher dose mainly by delivering extra 93 MUs in average. However, there was no significant difference in CIs and organs at risks (OARs) DVH. The relative changes in tumor size and CT values of the three patients in follow up were up to the Choi criteria and the three patients were all assessed as partial response. Conclusions The proposed SIB-IMRT may be a potential technique for achieving objective response and prolonging survival of selected GISTs patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study
    Cui, Haixia
    Li, Ying
    Huang, Wei
    Lu, Wenli
    Yi, Xin
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [2] Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study
    Haixia Cui
    Ying Li
    Wei Huang
    Wenli Lu
    Xin Yi
    Radiation Oncology, 17
  • [3] Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy
    Teng, Feng
    Meng, Lingling
    Zhu, Fuhai
    Ren, Gang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (02) : 496 - +
  • [4] Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations
    Guerrero, M
    Li, XA
    Ma, LJ
    Linder, J
    Deyoung, C
    Erickson, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 933 - 939
  • [5] Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
    Junlin Yi
    Xiaodong Huang
    Li Gao
    Jingwei Luo
    Shiping Zhang
    Kai Wang
    Yuan Qu
    Jianping Xiao
    Guozhen Xu
    Radiation Oncology, 9
  • [6] Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
    Yi, Junlin
    Huang, Xiaodong
    Gao, Li
    Luo, Jingwei
    Zhang, Shiping
    Wang, Kai
    Qu, Yuan
    Xiao, Jianping
    Xu, Guozhen
    RADIATION ONCOLOGY, 2014, 9
  • [7] Neoadjuvant hypofractionated intensity-modulated radiotherapy with a simultaneous integrated boost combined with capecitabine in locally advanced rectal cancer
    Vera Merino, M.
    Angel Schutte, D.
    Lopez-Zamora, B.
    Almada, M.
    Villasmil, L. Suarez
    Schworer, Y.
    Venencia, D.
    Zunino, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S155 - S156
  • [8] A prospective randomized comparison of simultaneous integrated boost with sequential boost intensity-modulated radiotherapy in locally advanced head and neck cancer
    Mani, Nilesh
    Aggarwal, Sushil K.
    Kumar, Ishan
    Mandal, Abhijit
    Jaiswal, Garima
    Ranjan, Rakesh
    Jaiswal, Anil K.
    Gupta, Neha
    Singh, Ankita
    Mourya, Ankur
    Aggarwal, Lalit M.
    Choudhary, Sunil
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S455 - S459
  • [9] Intensity-Modulated Radiotherapy With a Simultaneous Integrated Boost in Rectal Cancer
    Owens, R.
    Mukherjee, S.
    Padmanaban, S.
    Hawes, E.
    Jacobs, C.
    Weaver, A.
    Betts, M.
    Muirhead, R.
    CLINICAL ONCOLOGY, 2020, 32 (01) : 35 - 42
  • [10] A Comparison of Intensity-Modulated Radiotherapy With Simultaneous Integrated Boost With Three-Dimensional Conformal Radiotherapy With Sequential Boost for Locally Advanced Cervical Cancer: A Dosimetric Study
    Figueredo Negron, Carlos Ivan
    Gamboa Garay, Oscar
    Pabon Giron, Alexandra
    Esguerra Cantillo, Jose Alejandro
    Guerrero Lizcano, Eduardo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)